Noerr advises BBA Capital Partners on acquisition of a stake in Czech Quinta-Analytica


A Noerr team led by Barbara Kusak has advised BBA Capital Partners on its acquisition of a stake in the Czech company Quinta-Analytica s.r.o. The seller was the Genesis Private Equity Fund III managed by the Genesis Capital Group.

Quinta-Analytica is a leading clinical research company offering a wide range of services to pharmaceutical companies worldwide, including analytics, clinical trials, and research and development. Founded in 1996, the company today has a workforce 200+ and is headquartered in Prague, Czech Republic.

BBA Capital Partners is an investment company run and financed by its owners that offers long-term entrepreneurial capital to SME market leaders. Its “family equity” philosophy combines the long-term, strategic mindset of a family-owned business with sustainable and professional corporate development.

Advisors to BBA Capital Partners: Noerr s.r.o.

Barbara Kusak (team lead), Lucia Luptakova (lead associate), Michal Janicek, Filip Murar, Pavel Hrdy, Matej Korduliak (all Corporate/M&A, Prague)